John Oyler, BeiGene CEO (Paul Yeung/Bloomberg via Getty Images)
BeiGene CEO John Oyler steps up to the Big Pharma league with $16M in comp as shares sour
BeiGene’s compensation report is out — and it puts founder, chairman and CEO John Oyler in a very nice spot at the head of the maturing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
